A61M2210/105

METHODS AND DEVICES FOR DETERMINING A POSITION OF AN ENDOTRACHEAL TUBE
20210121651 · 2021-04-29 ·

Systems, methods, and devices are disclosed for accurately detecting a position of an endotracheal tube by sensing patient anatomy surrounding the endotracheal tube. Systems of the present disclosure include an endotracheal tube having at least one sensor supported by the endotracheal tube configured to detect surrounding patient anatomy. A signal processing unit can receive data from the sensor and can at least one of (i) identify the detected patient anatomy, for example, vocal cords, (ii) determine a distance between the detected patient anatomy and a known point on the endotracheal tube, and (iii) verify a positioning of the endotracheal tube within a tracheal or esophageal lumen of the patient. In some embodiments, the system can include at least one inflatable component that can extend along an outer surface of the endotracheal tube and support the at least one sensor.

SMART DEVICE AND SYSTEM FOR TREATMENT OF GASTRIC REFLUX

A smart device that monitors the condition of the lower esophagus by means of cameras, pH sensors, and other biometric sensors. The device may be equipped with movable arms that facilitate the collection of tissue biopsies from the esophagus as well as a reservoir that contains a medicament such as an antacid or other medicament useful for treating GERD. Data from the cameras and sensors may be transmitted and processed outside of the body and used to diagnose and treat esophageal disorders and can provide early detection of esophageal cancer or to treat GERD.

DRUG-COATED BALLOON CATHETERS FOR BODY LUMENS
20210113742 · 2021-04-22 ·

Various embodiments disclosed relate to drug-coated balloon catheters for treating, preventing, or reducing the recurrence of a stricture and/or cancer, or for treating benign prostatic hyperplasia (BPH), in a non-vascular body lumen and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent. In some embodiments, the balloon catheter includes a length-control mechanism which stretches and elongates the balloon when it is in a deflated state, giving the balloon a smaller cross-sectional deflated profile for tracking through the body lumen and for removal after treatment.

METHODS AND APPARATUS FOR TREATMENT OF A BODY CAVITY OR LUMEN
20210068887 · 2021-03-11 · ·

Methods and apparatus for the treatment of a body cavity or lumen are described where a heated fluid and/or gas may be introduced through a catheter and into treatment area within the body contained between one or more inflatable/expandable members. The catheter may also have optional pressure sensing elements which may allow for control of the pressure within the treatment zone and also prevent the pressure from exceeding a pressure of the inflatable/expandable members to thereby contain the treatment area between these inflatable/expandable members. Optionally, a chilled or room temperature fluid such as water may then be used to rapidly terminate the treatment session.

DRUG-COATED BALLOON CATHETERS FOR BODY LUMENS
20210052862 · 2021-02-25 ·

Various embodiments disclosed relate to drug-coated balloon catheters for treating strictures in body lumens and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent.

DRUG-COATED BALLOON CATHETERS FOR BODY LUMENS
20210052863 · 2021-02-25 ·

Various embodiments disclosed relate to drug-coated balloon catheters for treating strictures in body lumens and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent.

DRUG-COATED BALLOON CATHETERS FOR BODY LUMENS
20210052864 · 2021-02-25 ·

Various embodiments disclosed relate to drug-coated balloon catheters for treating strictures in body lumens and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent.

SUBMUCOSAL BIORESORBABLE DRUG ELUTING PLATFORM

Described here are systems and methods for delivering an active agent to target tissues of the ear, nose, or throat using a drug delivery platform having the therapeutic drug embedded as part of the drug delivery platform. The drug delivery platform is implanted into a target tissue, and the active agent elutes out of the body of the drug delivery platform for a target period of time, delivering a therapeutic dose of the drug for that period of time. The duration of therapy for an implant into a sinus tissue can be from 3 to 12 months, or longer, thereby providing relief for the full duration of an allergy season. Moreover, the duration of therapy can provide relief to individuals with chronic paranasal sinus condition symptoms for a period of time longer than presently available therapies, thus allowing for only semi-annual or annual applications of the therapy.

SLEEVE TUBE AND METHOD OF USE
20210205107 · 2021-07-08 · ·

Methods, systems, and devices are described for fabricating, providing, and using an orogastric tube. The orogastric tube may have, among other things: a proximal end section; a distal end section opposite the proximal end section and having a flexible, resilient curved portion; at least one sump channel extending from the proximal end section along a pre-determined length of the orogastric tube into the distal end section; at least one suction channel extending from the proximal end section along a pre-determined length of the orogastric tube into the distal end section; and optionally at least one balloon channel extending from the proximal end section along a pre-determined length of the orogastric tube to the distal end section. The optional balloon channel is in communication with an expandable balloon in the distal end section; and a main channel encloses a pre-determined length of the sump channel, the suction channel, and, if present, the balloon channel.

DRUG-COATED BALLOON CATHETERS FOR BODY LUMENS
20210205502 · 2021-07-08 ·

Various embodiments disclosed relate to drug-coated balloon catheters for treating strictures in body lumens and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent.